UNICA IRIS Institutional Research Information System

BOCCHETTA, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 95.757
NA - Nord America 4.439
AS - Asia 466
SA - Sud America 14
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 100.689
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 94.530
US - Stati Uniti d'America 4.419
UA - Ucraina 420
CN - Cina 386
SE - Svezia 275
DE - Germania 173
GB - Regno Unito 153
FI - Finlandia 100
FR - Francia 36
VN - Vietnam 32
IN - India 19
BE - Belgio 17
CA - Canada 16
SG - Singapore 14
RU - Federazione Russa 13
NL - Olanda 12
BR - Brasile 8
ES - Italia 8
TR - Turchia 5
EU - Europa 4
MX - Messico 4
RO - Romania 4
AU - Australia 3
IE - Irlanda 3
IL - Israele 3
AR - Argentina 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
IR - Iran 2
JP - Giappone 2
MU - Mauritius 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
LU - Lussemburgo 1
NG - Nigeria 1
PL - Polonia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 100.689
Salva come PNG Salva come JPEG
Città #
Cagliari 94.240
Fairfield 595
Chandler 471
Woodbridge 381
Houston 348
Ashburn 308
Ann Arbor 282
Wilmington 267
Seattle 258
Jacksonville 225
Cambridge 203
Nyköping 202
Dearborn 143
Boardman 97
Nanjing 77
New York 64
Boston 58
Shanghai 44
Beijing 42
Helsinki 40
Shenyang 36
Dong Ket 32
San Diego 32
Redwood City 27
Milan 25
Verona 23
Jinan 20
Southend 20
Nanchang 19
Mountain View 18
Changsha 17
Jiaxing 17
Hebei 15
Norwalk 15
Brussels 14
Guangzhou 13
Tianjin 13
London 12
Ningbo 12
Orange 12
Atlanta 11
Pune 11
Auburn Hills 9
Hangzhou 9
Hefei 9
Toronto 9
Los Angeles 8
Phoenix 8
Falls Church 7
Rome 7
San Mateo 7
Washington 7
Saint Petersburg 6
Augusta 5
Detroit 5
Lille 5
Suni 5
Tappahannock 5
Zhengzhou 5
Bisceglie 4
Konya 4
Kunming 4
Madrid 4
Sassari 4
Shaoxing 4
Taizhou 4
Brindisi 3
Chicago 3
Dresden 3
Dublin 3
Edinburgh 3
Gent 3
Halifax 3
Leawood 3
Mumbai 3
Pocatello 3
Suelli 3
Worcester 3
Azor 2
Borås 2
Buenos Aires 2
Cairo 2
Castelfranco Emilia 2
Cedar Knolls 2
Copenhagen 2
Costa Mesa 2
Delhi 2
Indiana 2
Kansas City 2
Kilburn 2
Millbury 2
Monserrato 2
Quzhou 2
Rotterdam 2
Santiago 2
Sassuolo 2
Sestu 2
Sofia 2
Spijkenisse 2
São Paulo 2
Totale 98.983
Salva come PNG Salva come JPEG
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 3.980
Bipolar disorder and antithyroid antibodies: review and case series 3.171
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.144
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.131
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 2.847
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.636
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.594
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.560
Long-term lithium and estimated glomerular filtration rate 2.532
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 2.430
null 2.366
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function 2.333
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.224
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.180
Fifteen-year follow-up of thyroid function in lithium patients 2.071
Online information seeking by patients with bipolar disorder: results from an international multisite survey 2.061
Lithium treatment and thyroid abnormalities 1.978
Internet use by patients with bipolar disorder: Results from an international multisite survey 1.961
Prediction of Lithium Response using Clinical Data 1.956
Ammonemia in bipolar patients on maintenance treatment with valproic acid 1.936
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 1.900
Psychotropic medication of acute episodes of mood disorders: Current prescription attitude in two psychiatric wards in Cagliari, Italy 1.819
Long term lithium treatment and survival from external causes including suicide 1.798
The Sardinian puzzle: concentration of major psychoses and suicide in the same sub-regions across one century 1.772
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters 1.754
Internet use by older adults with bipolar disorder: international survey results 1.721
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series 1.476
The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in italy 1.350
null 1.334
null 1.262
BIPOLAR DISORDER 1.240
Depressione post-partum: dalle basi biologiche allo sviluppo di nuove terapie 1.225
null 1.199
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.150
A retrospective case series of bipolar patients during pregnancy: lithium prophylaxis, risk of recurrences and maternal/neonatal complications 1.132
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients 1.058
L’uso dei farmaci psicotropi in 6 regioni italiane 986
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 964
MORTALITY FOLLOW-UP OF PATIENTS SINCE COMMENCING LITHIUM THERAPY 953
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 917
null 914
Six-year follow-up of thyroid function during lithium treatment 900
Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in Sardinia 866
Thyroid abnormalities during lithium treatment 857
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 838
Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts 813
Positive association between dopamine D2 receptor gene and migraine without aura in a Sardinian sample- 800
The course of thyroid abnormalities during lithium treatment: a two-year follow-up study 796
null 749
Family-based association study between bipolar disorder and DRD2, DRD4 and SERT in Sardinia 748
Calcitonin decreases lithium plasma levels in man. Preliminary report 719
A double blind study of minaprine versus amitriptyline in major depression 717
Thyroid function during carbamazepine 697
An interaction between carbamazepine and fluvoxamine 673
A double-blind study of l-sulpiride versus amitriptyline in lithium-maintained bipolar depressives 658
Association between dopamine receptor genes and migraine without aura in a Sardinian sample 645
Association and linkage studies of affective disorders 608
Bipolar affective disorder and heterozygous beta-thalassaemia 604
Linkage between X-chromosome markers and mainc-depressive illness 582
Mania and fluvoxamine. 579
The use of dopamine agonists in the treatment of schizophrenia 565
null 564
Properties of benzodiazepine binding sites in peripheral tissues 555
Is bipolar disorder linked to Xq28? 550
Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro 544
Familial rates of affective illness in Sardinia with special reference to schizoaffective disorder 539
Inhibition of 3H-MPTP binding to rat brain by pargyline 538
Heterogeneity of monoaminergic vesicular carriers: pharmacological evidence using MPP+ as a marker 528
null 497
Characterization of [3H]MPTP binding sites 493
null 486
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain and inhibition of dopamine oxidative deamination in vivo and in vitro 484
Genetic linkage and association studies in affective disorders 456
Affective psychosis, Hashimoto's thyroiditis, and brain perfusion abnormalities: case report 382
null 366
Ten-year follow-up of thyroid function in lithium patients 293
HETEROZYGOUS BETA-THALASSAEMIA AS A SUSCEPTIBILITY FACTOR IN MOOD DISORDERS: EXCESSIVE PREVALENCE IN BIPOLAR PATIENTS 244
PSYCHOTIC MANIA IN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT SUBJECTS 207
Reconsidering risk factors for renal dysfunction in lithium-treated patients 180
International multi-site survey on the use of online support groups in bipolar disorder 139
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium 98
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo 92
A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine axidase 83
MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity 77
Dopamine agonists in the treatment of schizophrenia 64
Totale 100.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019739 0 0 0 0 0 0 0 0 0 0 345 394
2019/202020.101 970 477 138 444 7.046 5.092 2.801 748 508 487 462 928
2020/202131.611 902 1.176 1.253 7.724 6.169 3.929 2.570 2.202 835 1.988 1.812 1.051
2021/20227.602 1.019 641 417 520 707 509 372 448 628 824 828 689
2022/20239.873 850 1.444 1.295 911 951 985 438 753 765 522 612 347
2023/20247.573 494 986 458 649 825 1.289 1.141 586 413 589 143 0
Totale 100.888